Literature DB >> 12631186

C-1 esterase inhibitor dysfunction localised to the periodontal tissues: clues to the role of stress in the pathogenesis of chronic periodontitis?

A Roberts1, M Shah, I L C Chapple.   

Abstract

BACKGROUND: C1-esterase inhibitor (C1eIn) is an important modulator of complement activation via the classical pathway. Deficiencies or dysfunction involving this inhibitor underlie the condition of angioneurotic oedema. AIM: The purpose of this report is to describe a female patient who presented at the age of 24 years with an apparently aggressive form of periodontitis and severe oedema, localised to the free gingival tissues. After 21 years of repeated surgical reduction of the gingiva, a diagnosis of C1eIn dysfunction was made.
METHODS: Exhaustive serological investigations were performed along with histopathology.
RESULTS: All investigations were unremarkable, until the function of the C1eIn molecule was investigated. These demonstrated a functional activity of only 29% and a raised C1q at 157 mg/l. Subsequent repeated investigation with careful specimen handling demonstrated undetectable levels of C1eIn and normal C1q. A diagnosis of C1eIn dysfunction was made, although at present it is unclear whether this represents an unusual variant of hereditary dysfunctional C1eIn deficiency. The patient was managed by various means, including steriodal and non-steroidal drugs, the latter forming part of her maintenance regime.
CONCLUSIONS: To our knowledge, this is the first case of angio-oedema localised to the free gingiva. The role of stress in the acute exacerbations of oedema and bone loss is discussed along with the diagnostic pitfalls associated with this case.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631186     DOI: 10.1034/j.1600-051x.2003.01266.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  7 in total

1.  Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).

Authors:  Robert J Boackle; Quang L Nguyen; Renata S Leite; Xiaofeng Yang; Jana Vesely
Journal:  Mol Immunol       Date:  2005-03-05       Impact factor: 4.407

Review 2.  Complement and periodontitis.

Authors:  George Hajishengallis
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

3.  Transcriptome Analysis of Monocytes and Fibroblasts Provides Insights Into the Molecular Features of Periodontal Ehlers-Danlos Syndrome.

Authors:  Zhuoyi Liao; Tian Zhao; Ningxiang Wang; Jiaqi Chen; Weibin Sun; Juan Wu
Journal:  Front Genet       Date:  2022-04-28       Impact factor: 4.772

Review 4.  Complement-targeted therapeutics in periodontitis.

Authors:  George Hajishengallis; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 5.  Complement-Dependent Mechanisms and Interventions in Periodontal Disease.

Authors:  George Hajishengallis; Tetsuhiro Kajikawa; Evlambia Hajishengallis; Tomoki Maekawa; Edimara S Reis; Dimitrios C Mastellos; Despina Yancopoulou; Hatice Hasturk; John D Lambris
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

6.  C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome.

Authors:  Rebekka Gröbner; Ines Kapferer-Seebacher; Albert Amberger; Rita Redolfi; Fabien Dalonneau; Erik Björck; Di Milnes; Isabelle Bally; Veronique Rossi; Nicole Thielens; Heribert Stoiber; Christine Gaboriaud; Johannes Zschocke
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

7.  Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3.

Authors:  Michal Potempa; Jan Potempa; Tomasz Kantyka; Ky-Anh Nguyen; Katarzyna Wawrzonek; Surya P Manandhar; Katarzyna Popadiak; Kristian Riesbeck; Sigrun Eick; Anna M Blom
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.